CVX Keeps Rising — But Options Traders Are Hedging

Chevron closed Tuesday at $217.77, up another 3.8% on the week, yet the most pointed shift in this week's data is not the price — it is a quiet but clear move toward caution in the options market, arriving just as the stock pushes toward the top of the analyst target range.

Options positioning has become measurably more defensive over the past two sessions. The put/call ratio jumped to 0.78, well above its 20-day average of 0.72 and running at 1.74 standard deviations above the mean — the highest defensive skew recorded in roughly a month. That reading is still below the 52-week high of 0.96, so this is not an extreme, but the direction is notable: the PCR had been running in a calm 0.67–0.70 band through most of August and early September before spiking this week as the stock broke through the $215 level.

The short interest picture has changed since last week's report. The previous note flagged a sharp 35% week-on-week rebuild in SI — that spike has since partially unwound. Short interest now registers at roughly 1.1% of free float, down 2% in the past session after peaking mid-week near 1.15%. The week-on-week change still shows a 32% increase relative to the prior Tuesday, confirming that bears did step back in — but Tuesday's partial retreat suggests the position build is losing momentum rather than accelerating. Borrow conditions remain entirely unrestrictive: availability is effectively uncapped, and cost-to-borrow has fallen 22% on the week to just 0.32%. Shorting CVX is cheap and easy. The modest short interest here reflects conviction, not a capacity constraint.

Analyst targets are now being tested in real time. A cluster of target raises landed on September 3 — BMO Capital lifted to $235, Piper Sandler to $243, Wells Fargo to $230 — all maintaining positive ratings and all revising materially higher from prior targets in the $207–$226 range. Morgan Stanley moved to $218 in late August, also constructive. The lone dissent in recent weeks came from Barclays, which trimmed its target to $208 in mid-August while keeping an Equal-Weight rating, and has since raised it back to $216 — a signal that even the skeptics are moving with the tape. The mean price target now stands at $221, only $3.40 above Tuesday's close. The stock has essentially caught up to consensus. Bulls lean on the LNG expansion pipeline, Guyana production ramp, and a fortress balance sheet. Bears point to political risk in key operating regions and Q1 2026 earnings that included timing-effect headwinds. The dividend factor scores in the 85th percentile, reflecting Chevron's track record of yield maintenance through cycles. EV/EBITDA is running at 7.0x, down slightly on the month, with a P/E near 14.9x — neither stretched nor cheap for an integrated major.

Insider activity from mid-August deserves a note. CEO Michael Wirth sold 306,789 shares at around $200.44, netting roughly $61.5 million, while simultaneously exercising options on 317,100 shares at an $88.20 strike — a classic cashless exercise-and-sell sequence. None of the recent trades were conducted under a 10b5-1 pre-arranged plan, which is unusual for sales of this magnitude and typically warrants closer attention. A separate open-market sale by the President of DM&C (Andrew Walz) of 16,800 shares at $201 adds to the net selling picture. Across all insiders, the 90-day net flows show 1.17 million shares sold worth roughly $229 million. These are largely exercise-related mechanics rather than pure conviction sells, but the scale is notable at a stock that has since rallied another 8%+ from the transaction levels.

Berkshire Hathaway's 4.3% stake, last reported at 84.4 million shares as of June 30, remains the most-watched passive position on the register. The Vanguard 13G/A filed in March showed zero shares — reflecting a reorganisation across Vanguard entities rather than an exit — with Vanguard Capital Management's subsequent April 13G restating a 7.07% position. No 13D activist is present. All major holders appear passive and stable.

The next earnings event is October 30. Last quarter's print produced a muted 0.45% single-day move. The five-day reaction drifted negative at around -3%. With the stock now trading within $3 of mean analyst targets and the put/call ratio ticking higher into the rally, the dynamic to watch into month-end is whether options hedging continues to build as the stock tests — and potentially exceeds — the consensus view of fair value.